The research teams of Prof. Xinjing Tang and Prof. Zhenjun Yang collaborated on the targeted degradation of Lin28B using Pre-let-7-PROTACs for hepatocellular carcinoma therapy
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research teams of Prof. Xinjing Tang and Prof. Zhenjun Yang collaborated on the targeted degradation of Lin28B using Pre-let-7-PROTACs for hepatocellular carcinoma therapy[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(3): 328-328.
>
>